Abstract
The variation in inhibitor specificity for five different amine inhibitors bound to CST, BT, and the cold-adapted AST has been studied by use of association constant measurements, structural analysis of high-resolution crystal structures, and the LIE method. Experimental data show that AST binds the 1BZA and 2BEA inhibitors 0.8 and 0.5 kcal/mole more strongly than BT. However, structural interactions and orientations of the inhibitors within the S1 site have been found to be virtually identical in the three enzymes studied. For example, the four water molecules in the inhibitor-free structures of AST and BT are channeled into similar positions in the S1 site, and the nitrogen atom(s) of the inhibitors are found in two cationic binding sites denoted Position1 and Position2. The hydrophobic binding contributions for all five inhibitors, estimated by the LIE calculations, are also in the same order (−2.1 ± 0.2 kcal/mole) for all three enzymes. Our hypothesis is therefore that the observed variation in inhibitor binding arises from different electrostatic interactions originating from residues outside the S1 site. This is well illustrated by AST, in which Asp 150 and Glu 221B, despite some distance from the S1 binding site, lower the electrostatic potential of the S1 site and thus enhance substrate binding. Because the trends in the experimentally determined binding energies were reproduced by the LIE calculations after adding the contribution from long-range interactions, we find this method very suitable for rational studies of protein–substrate interactions.
Keywords: trypsin, inhibitor specificity, electrostatic interactions, cold-adaptation, molecular dynamics, binding free energy
The binding of protein and peptide substrates to the pancreatic serine proteinases is characterized by well-defined binding sites, including a primary specificity pocket (S1 site, nomenclature from Schechter and Berger 1967) and subsites (secondary binding sites), anchoring the polypeptide chain of the substrate at both sides of the primary binding residue (P1). The primary specificity of the serine proteinases is to a large extent determined by the shape and charge of the S1 pocket. It is well documented that Asp 189, at the bottom of the active site pocket of trypsin, is the major determinant for the narrow specificity of trypsin for positively charged substrates. In addition, the hydrophobic walls of the pocket create a favorable environment for the long aliphatic and unbranched parts of the basic arginine and lysine side chains. In contrast, chymotrypsin possesses a wider and uncharged S1 pocket, and prefers large hydrophobic and aromatic P1 side chains. However, a number of studies have revealed that several residues distal to the S1 site are essential for the specificity (see, for example, Hedstrom 1996; Perona and Craik 1997). Attempts to convert trypsin into a chymotrypsin-like or elastase-like enzyme (Hedstrom et al. 1992, 1994a,b; Hung and Hedstrom 1998) have all shown that the specificity of serine proteinases is much more complex than previously thought, and the structural sources of the substrate discrimination are still not fully understood.
Measurements of the association constants (Ka) for complexes between 18 different P1 variants of the BPTI and four serine proteinases (bovine chymotrypsin, human neutrophile elastase, AST, and BT) revealed that both BT and AST had, as expected, a specific and narrow affinity for the cognate Lys and Arg side chains (Krowarsch et al. 1999). However, Ka-values for AST were 100-fold higher than the corresponding values for BT for both P1 Lys and Arg, whereas binding of the noncognate P1 residues was not significantly different in the two trypsins. Another comparative kinetic study of AST and BT, using a small synthetic substrate (benzoyl-D,L-arginine p-nitroanilide), showed that the salmon enzyme possessed a 35-fold higher catalytic efficiency (measured by the kcat/Km ratio) at 4°C compared with BT (Outzen et al. 1996). The catalytic efficiency for CHST is lower than for AST (22-fold higher than BT at 5°C; Sekizaki et al. 2000; Toyota et al. 2002), even if there are only four differences in the amino acid sequences (positions 28, 125, 152, and 244) of the fish enzymes, and the RMSD value for the main-chain atoms of the two structures is 0.36 Å (Toyota et al. 2002). Residue 152 is Ser in AST and Lys in CHST, which changes the overall charge from −4 (AST) to −3 (CHST), and the electrostatic potential of the S1 site in the latter is slightly altered. For AST, the Km value is reduced in the catalysis, implying a stronger binding of the substrate in the S1 site. Increased substrate affinity has also been observed for other cold-adapted trypsins (Kristjansson et al. 1997), whereas higher catalytic efficiency appears to be a general feature of cold-adapted enzymes; see, for example, Smalås et al. (2000). Comparison of the crystal structures of the AST-BPTI and BT-BPTI complexes (Helland et al. 1998) revealed small differences in binding modes of the two enzymes, both at primary and secondary binding sites. The P1 Lys Nζ atom of BPTI forms a hydrogen bond directly to the carboxyl group of Asp 189 in AST-BPTI, whereas it only interacts via a water molecule in the BT-BPTI complex. Differences in the secondary binding sites indicate looser binding of the S′side of AST-BPTI. The P1 Gly variant of the BPTI complex has no side chain penetrating the S1 pocket of trypsin, and is therefore expected to give an estimate of the contribution to the binding energy from secondary binding sites only. The similar association energy between the BPTI P1 Gly variant bound to BT and AST, both in the order of 6 kcal/mole (Krowarsch et al. 1999), suggests that these interactions are similar in the two homologs and that they contribute significantly to the overall complex formation.
The observations mentioned earlier suggest that the higher substrate affinities of AST mainly arise from stronger interactions within the S1 site. This encouraged us to further investigate the nature and the differences among the primary binding sites of trypsins. The association capacities and binding patterns for three different trypsins (AST, CST, and BT), in complex with a series of small synthetic inhibitors that are only in contact with the S1 site, have been investigated. In this study, four AST and four BT crystal structures have been determined; association constants have been measured for the inhibitors bound to AST, CST, and BT; and the binding free energies have been calculated using the LIE approach (Åqvist et al. 1994). The structures have in detail been compared with a series of corresponding BT complexes (Marquart et al. 1983; Kurinov and Harrison 1994), BT complexed with BPTI P1 Gly and P1 Phe, (Helland et al. 1999b) and the AST-BPTI complex (Helland et al. 1998). The synthetic inhibitors included in this study are, in addition to 1BZA, all amines of various lengths attached to a phenyl group (Fig. 1 ▶).
Results
Association constants
The measured association constants (Ka) for the synthetic inhibitors in complex with AST, CST, and BT clearly rank 1BZA as the most potent inhibitor of all the trypsins followed by 2BEA and 3PEA (Tables 1a, 1b). The 4PPA binds more favorably than 5PBA (the longest one) to both AST and BT, whereas the reverse is found for CST. The cold-adapted and overall negatively charged AST (pI = 4.7; Outzen et al. 1996) binds the two smallest inhibitors stronger than the cationic CST and BT (pI above 10; Outzen et al. 1996). The association constants of 1BZA and 2BEA bound to AST are 1.4–3.5 times higher compared with CST and BT. CST is found to have the highest affinity for the longer inhibitors, and is, for example, for 5PBA 20 times higher compared with BT. The association constants for 4PPA and 5PBA are, however, very weak (up to several thousand fold lower Ka-values than for 1BZA), and the accuracy may therefore be expected to be somewhat lower for these measurements compared with the best inhibitors. The differences among the weakly bound complexes should therefore only be taken as relative indications. We have introduced numbers 1–5 in the abbreviations (1BZA, 2BEA, 3PEA, etc.), which roughly refer to the lengths of the inhibitors. See Figure 1 ▶ and Table 1b for more details.
Table 1a.
AST | CST | BT | |
kcat (S−1) | 30.4 | 87.5 | 88.0 |
Km (M) | 8.96 * 10−7 | 2.61 * 10−6 | 5.19 * 10−6 |
kcat/Km (S−1M−1) | 3.39 * 107 | 3.35 * 107 | 1.70 * 107 |
Table 1b.
Inhibitor | AST | CST | BT | BTa |
1BZA | 1.65 * 105 | 1.06 * 105 | 4.71 * 104 | 1 * 104 |
2BEA | 6940 | 4870 | 3120 | |
FBA | 2326 | |||
AMC | 855 | |||
3PEA | 1029 | 1150 | 188 | 91 |
4PPA | 293 | 520 | 38 | 31 |
5PBA | 243 | 573 | 28 | 50 |
The Ka is 1/Kd where Kd is found from the Dixon plot equation defined in
Materials and Methods.
a Previously reported values are from Kurinov and Harrison (1994).
X-ray structures
Crystals were obtained for three AST complexes (AST-2BEA, AST-3PEA, AST-4PPA) and three BT complexes (BT-2BEA, BT-3PEA, BT-5PBA) in addition to the inhibitor free enzymes (AST-Free, BT-Free). The two latter are from unsuccessful trials of crystallization with ANL and 4PPA for AST and BT, respectively. All of the structures diffracted to high resolution (1.15–1.83 Å) and were refined to R-values between 11.3% and 18.9%. The corresponding R-free values are not more than 5.5% higher than the conventional R-factors. Mean coordinate errors are estimated to be in the range of 0.06–0.17 Å and RMS deviations in the range of 0.008–0.015 Å for bond lengths. See Tables 2 and 3 for more details. All inhibitors have been refined with full occupancy so that the relative B-factors (Tables 4, 5) reflect both the binding affinity and the occupancy in the structures (in addition to dynamic and static disorder). The relative B-factor is:
Table 2.
Anionic salmon trypsin | Bovine trypsin | |||||||
Inhibitor | Benzylamine | Phenylethylamine | Phenylpropylamine | No inhibitor | Benzylamine | Phenylethylamine | Phenylbutylamine | No inhibitor |
Abbreviation | AST-2BEA | AST- 3PEA | AST-4PPA | AST-Free | BT-2BEA | BT-3PEA | BT-5PBA | BT-Free |
Max. diffraction (Å) | 1.83 | 1.5 | 1.7 | 1.53 | 1.15 | 1.15 | 1.3 | 1.15 |
Temperature (K) | 295 | 295 | 295 | 120 | 120 | 100 | 100 | 100 |
Beamline | SNBL MAR | DESY X31 MAR | SNBL MAR | SNBL | SNBL | ID14-EH4 ADSC | ID14-EH4 ADSC | ID14-EH4 ADSC |
Detector | 18 cm | 18 cm | 18 cm | MAR345 | MAR345 | CCD | CCD | CCD |
Wavelength (Å) | 0.873 | 1.070 | 0.873 | 0.873 | 0.800 | 0.932 | 0.932 | 0.932 |
Cell (Å) | a = 45.03 | a = 74.94 | a = 44.94 | a = 71.43 | a = 54.15 | a = b 3 54.59 | a = b = 54.60 | a = b = 54.51 |
b = 48.18 | b = 85.09 | b = 48.27 | b = 83.26 | b = 56.73 | c = 107.19 | c = 107.10 | c = 107.28 | |
c = 83.01 | c = 32.19 | c = 83.10 | c = 30.87 | c = 66.25 | γ = 120 | γ = 120 | γ = 120 | |
Space group | P212121 | P21212 | P212121 | P21212 | P212121 | P3121 | P3121 | P3121 |
No. of observations (∞-max. resol.) | 68,761 | 111,508 | 51,387 | 156,549 | 801,482 | 633,227 | 638,726 | 608,228 |
No. of unique reflections | 14,865 | 32,883 | 19,106 | 28,477 | 71,444 | 63,049 | 41,821 | 62,502 |
Rmerge (%) | 6.8 (12.2) | 4.8 (27.1) | 7.0 (24.3) | 7.5 (36.1) | 5.5 (35.6) | 7.8 (40.1) | 5.9 (16.1) | 5.4 (35.3) |
I/σI | 8.5 (5.5) | 10.1 (2.8) | 8.3 (3.0) | 2.6 (2.0) | 7.2 (1.9) | 4.0 (1.8) | 5.1 (1.4) | 6.4 (2.1) |
Completeness (%) | 90.6 (57.0) | 97.9 (93.4) | 93.8 (96.4) | 99.5 (98.2) | 97.3 (91.6) | 94.8 (84.2) | 91.5 (87.5) | 94.6 (85.7) |
Wilson B-factor (Å2) | 10.58 | 14.25 | 11.32 | 11.43 | 10.17 | 11.21 | 12.25 | 10.88 |
The outer shell values (10th bin) are shown in parentheses.
Table 3.
AST-2BEA | AST-3PEA | AST-4PPA | AST-Free | BT-2BEA | BT-3PEA | BT-5PBA | BT-Free | ||
Refinement program | X-PLOR | X-PLOR | X-PLOR | SHELXL | SHELXL | SHELXL | SHELXL | SHELXL | |
Resol. in final refinement (Å) | 8.0–1.83 | 8.0–1.50 | 8.0–1.70 | 8.0–1.53 | 8.0–1.15 | 8.0–1.15 | 8.0–1.3 | 8.0–1.15 | |
No. of reflections | 14,637 | 32,682 | 18,880 | 28,246 | 70,363 | 62,855 | 41,657 | 62,277 | |
% used for R-free calculations | 10 | 7 | 10 | 7 | 5 | 5 | 5 | 5 | |
R-factor including all data (%) | 16.2 | 18.9 | 17.6 | 17.74 | 11.32 | 13.92 | 14.13 | 13.77 | |
R-free (%) | 20.7 | 21.7 | 21.6 | 22.91 | 15.48 | 18.73 | 18.30 | 18.75 | |
No. of protein atoms | 1670 | 1684 | 1666 | 1697 | 1728 | 1699 | 1670 | 1687 | |
No. of water molecules | 75 | 109 | 73 | 179 | 286 | 225 | 194 | 254 | |
No. of other solvent molecules | — | — | 1 MPD | 2 SO42− | 5SO42−, 2 GOL, 1 Tris | 1 GOL | 1 GOL | 1 GOL | |
No. of alternative side-chain conformations | 1 | 5 | — | 4 | 14 | 10 | 6 | 7 | |
Mean B-factors (Å2) | |||||||||
All atoms | 11.06 | 15.68 | 11.98 | 14.16 | 15.47 | 16.94 | 17.42 | 18.08 | |
Protein | 10.71 | 14.84 | 11.49 | 12.86 | 13.21 | 15.77 | 16.97 | 16.98 | |
Water molecules | 18.99 | 27.60 | 20.44 | 24.60 | 27.49 | 26.00 | 23.04 | 24.87 | |
Inhibitor | 7.57 | 22.01 | 19.96 | — | 17.54 | 24.48 | 47.00 | — | |
RMS deviations from ideal geometry | |||||||||
Bond lengths (Å) | 0.008 | 0.011 | 0.008 | 0.009 | 0.015 | 0.015 | 0.011 | 0.015 | |
Angles | 1.726° | 1.756° | 1.753° | 0.024 Å | 0.032 Å | 0.031 Å | 0.028 Å | 0.032 Å | |
Luzatti (1952) coordinate error (Å) | 0.15 | 0.17 | 0.17 | 0.13 | 0.06 | 0.07 | 0.08 | 0.08 |
Table 4.
AST-1BZA | AST-2BEA | AST-3PEA | AST-4PPA | AST-Free | AST-BPT1 | ||
Contacts to | NH1 | NH2 | NH1 | NH1 | NH1 | OW3 | Nζ |
Asp 189 Oδ1 | 2.87 | (3.73) | 3.33 | 3.14 | 3.46 | 2.85 | 3.35 |
Asp 189 Oδ2 | (3.55) | 2.84 | 2.70 | (3.55) | (3.73) | 3.18 | (3.73) |
Ser 190 O | 3.17 | 3.34 | 2.86 | 3.16 | 3.07 | 2.93 | 2.78 |
Ser 190 Oγ | 3.04 | 3.15 | 3.01 | 3.40 | 3.07 | ||
Gly 219 O | 2.87 | 3.13 | |||||
OW1 | 2.97 | 2.79 | 2.75 | 2.72 | 2.96 | ||
OW2 | 2.95 | 2.94 | 3.08 | 3.45 | 3.05 | ||
Cys 191 C-Trp 215 C | 7.83 | 8.05 | 8.46 | 8.23 | 8.10 | 8.28 | |
Relative B-factor of inhibitor | 1.03 | 0.71 | 1.48 | 1.74 | 0.48a |
Distances longer than 3.5 Å are given in parentheses, and the width of the pocket is taken as the Cys 191 C to Trp 215 C distance. Relative B-factors the inhibitors (〈B-factorinhib〉/〈B-factorprot〉) are also included.
a Side-chain atoms only.
Table 5.
BT-1BZA | BT-2BEA | BT-ANL | BT-3PEA | BT-5PBA | BT-Free | CST-1BZA | |||
Contacts to | NH1 | NH2 | NH1 | NH1 | NH1 | NH1 | OW3 | NH1 | NH2 |
Asp 189 Oδ1 | 2.87 | (3.78) | 3.34 | 3.48 | 3.35 | 3.36 | 2.93 | 2.88 | (3.78) |
Asp 189 Oδ2 | (3.51) | 2.92 | 2.79 | (3.99) | (3.74) | (3.61) | 3.12 | (3.48) | 2.89 |
Ser 190 O | 3.22 | 3.40 | 2.77 | 3.10 | 3.00 | 2.78 | 2.66 | 3.17 | |
Ser 190 Oγ | 3.04 | 2.97 | 3.14 | 3.16 | 3.21 | 3.01 | |||
Gly 219 O | 2.82 | 2.90 | 2.86 | ||||||
OW1 | 2.94 | 2.84 | 2.90 | 2.99 | 2.81 | ||||
OW2 | 3.13 | 2.86 | 3.11 | 3.44 | (3.81) | 3.28 | |||
Cys 191 C-Trp 215 C | 7.98 | 8.35 | 8.33 | 8.30 | 8.22 | 8.25 | 7.83 | ||
Relative B-factor of inhibitor | 1.56 | 1.33 | 2.30 | 1.55 | 3.22 | 0.78 |
Distances longer than 3.5 Å are given in parentheses, and the width of the pocket is taken as the Cys 191 C to Trp 215 C distance. Relative B-factors for the inhibitors (〈B-factorinhib. 〉 /〈B-factorprot.〉) are also included.
The electron density maps of the AST structures given in Figure 2 ▶ show that the smallest inhibitor (2BEA) is best defined in the 2Fo–Fc map, whereas the longer (3PEA, 4PPA) have poorer electron density. This is particularly pronounced for the carbon attached to the amine nitrogen of the inhibitor (the NH1 atom), which implies some degree of flexibility in this region. Also, the phenyl rings of 3PEA and 4PPA are not fully defined in the electron density maps, reflected through higher relative B-values for the inhibitors (Table 4). On the contrary, the electron density of the inhibitor in the previously reported AST-1BZA is very precise (Fig. 2A ▶; Leiros et al. 2001).
The BT-ANL structure has been presented elsewhere (Leiros et al. 2001), but details of the inhibitor interactions will be discussed here. The observed negative difference electron density adjacent to NH1 and one poorly defined C-C bond in the ring (Fig. 2E ▶) is likely to be explained by a genuine occupancy of the inhibitor lower than 1. The inhibitor and three surrounding water molecules are well defined in the electron density maps in the BT-2BEA structure (Fig. 2F ▶). When BT is inhibited by 2BEA, the amine is very well defined in electron density maps and three water molecules surround the inhibitor (Fig. 2F ▶). For the two longer inhibitors, 3PEA and 5PBA, the carbon next to NH1 is well defined (Fig. 2G,H ▶), which is not the case for AST-3PEA or AST-4PPA. Although the phenyl ring of BT-5PBA could be placed at different positions, we chose the one that best fitted the observed 2Fo–Fc electron density.
Five water molecules with well-defined electron densities are found in the S1 binding site of the AST-Free structure. OW5 has a somewhat larger density compared with the other water molecules, and could be a disordered ANL molecule (data not shown). In the BT-Free structure, there are four water molecules filling the active site. These waters in both structures superimpose very well on the corresponding solvent molecules in BT-K15G, which also has an “empty” active site because the P1 residue of BPTI is mutated.
Structural comparison
The superposition of the present trypsin amine inhibitor complexes onto the respective AST-1BZA (Fig. 3A ▶) and BT-1BZA (Fig. 3B ▶) complexes shows that the inhibitor amine nitrogen persistently occupies one of the guanidine nitrogen positions of 1BZA. The amine group is turned toward Gly 219 (Position1) in the BEA and its analogs (AST-2BEA, BT-2BEA, BT-AMC, BT-FBA; Fig. 4C ▶), whereas it is turned in the opposite direction (Position2), toward Ser 190, in the complexes with longer inhibitors (3PEA, 4PPA, 5PBA; Fig. 3A,B ▶). The principal interactions in Position1 involve contacts to Asp 189 Oδ2, Ser 190 O, Glu 219 O, and OW1, whereas the main interactions in Position2 are with Asp 189 Oδ1, Ser 190 O, Ser 190 Oγ, OW1, and OW2 (Tables 4, 5; Fig. 4 ▶). The latter orientation is also in accordance with the binding of the lysine side chain in the trypsin BPTI complexes (Rühlmann et al. 1973; Helland et al. 1998). The water mediated (OW1) hydrogen bonds between the inhibitor amines and Asp 189 are replaced with direct bonds to Asp 189 and Gly 219 in the 1BZA complexes. The water molecule (OW2) that bridges the amine nitrogen and the carbonyl oxygens of Val 227 and Trp 215 of AST and BT is also present in the 1BZA complexes. A second water molecule (OW2) that bridges the amine nitrogen and the carbonyl oxygens of Val 227 and Trp 215 of trypsin is also present in the 1BZA complexes. To summarize, there are no significant differences between the AST and BT inhibitor binding interactions as judged from the crystal structures, and the 1BZA binding pattern is identical among AST, CST, and BT, as previously reported (Smalås et al. 1994; Schrøder et al. 1998).
The orientations and positions of the phenyl groups are to a high degree conserved for all the short-chain inhibitors (1BZA, 2BEA, ANL, AMC, FBA), whereas the phenyl groups of the longer inhibitors are moved toward the active site entrance according to their increasing length (Fig. 3A,B ▶). The latter will thus be much more exposed to solvent when bound to the active site of the trypsins as compared with the short chain. Although the phenyl group of ANL in the BT-ANL complex is slightly rotated compared with the other short-chain inhibitors, it is buried equally deep in the pocket, as shown in Figure 4B ▶.
Kurinov and Harrison (1994) have previously reported a specificity pocket arrangement corresponding to our observations for the short-chain synthetic inhibitors (AMC, FBA) in complex with BT, where the amine group at Position1 interacts with Gly 219, similar to the situation in AST-2BEA and BT-2BEA. For the longer inhibitors of that study (3PEA, 4PPA, 5PBA), however, a binding pattern different from ours was reported (Fig. 4D ▶–F). They report the three inhibitors to bind deeper in the pocket, with the amino group at the position of our OW1, forming direct interactions to Asp 189 Oδ2 (2.7–2.8 Å), and the second carbon atom attached to NH1 located <3.0 Å from Ser 190 O flanking Position2. In addition, 5PBA in the previously reported BT-5PBA structure have the phenyl group bent toward one of the pocket walls, covering the OW4 water position in our BT-5PBA structure (Fig. 4F ▶).
Calculated binding constants
The free energies for binding five of the synthetic inhibitors given in Figure 1 ▶ to AST, CST, and BT, respectively, have been calculated with the LIE method (Åqvist et al. 1994). The individual contributions from polar (Vel) and nonpolar (Vvdw) interactions are shown in Table 6, and the resulting calculated association energies (ΔGcalc) are shown in Table 7. To facilitate the discussion, we transformed the measured association constants (Ka-values in Table 1b) into ΔGexp in kcal/mole (ΔGexp = −(RT ln Ka)), as given in the table. The LIE calculations correctly predict that 1BZA binds far more strongly than any of the other synthetic inhibitors studied here for all three trypsins. Furthermore, the calculations also show that 1BZA binds more favorably to AST and CST as compared with BT. In terms of absolute free energies, the calculated values for 1BZA deviate up to about 1.3 kcal/mole from the measured values. The ΔGcalc for 1BZA is in the order of 4–5 kcal/mole more favorable than the second strongest inhibitor, whereas the measured energies show corresponding differences in the range of 1.6–1.9 kcal/mole for the three trypsins. The relative order of association for the weaker amine inhibitors is also reproduced. The largest deviation is found for BT bound to 2BEA, for which the calculations predict a binding free energy of −2.4 kcal/mole, a value 2.3 kcal/mole more positive compared with the experimental value (−4.7 kcal/mole). In this case, the BT-2BEA simulation started from the X-ray structure with the amine nitrogen in the position where it binds to Gly 219, but during the MD simulations, the inhibitor amine switches interaction pattern and a water molecule gets trapped at the initial amine position. Thus, the calculated too positive binding free energy for this inhibitor with BT is caused by a significant change in the principal hydrogen-binding network. Once this network of hydrogen bonds is broken, the amine flips and interacts with Asp 189 from the second position toward Ser 190. However, this is also observed in both AST and CST, but here the inhibitor alternates between the two positions.
Table 6.
AST | CST | BT | Water | |||||
1BZA | −141.7 | −12.6 | −142.5 | −12.5 | −142.6 | −12.1 | −129.9 | −1.5 |
2BEA | −139.3 | −16.3 | −141.4 | −16.5 | −138.4 | −16.5 | −136.6 | −4.5 |
3PEA | −142.8 | −16.4 | −142.1 | −17.1 | −142.4 | −16.5 | −139.4 | −6.1 |
4PPA | −141.8 | −20.4 | −144.0 | −18.9 | −141.6 | −19.4 | −141.5 | −7.7 |
5PBA | −143.2 | −22.4 | −142.5 | −20.6 | −144.4 | −21.5 | −142.2 | −9.5 |
Table 7.
AST | CST | BT | |||||||||||||
ΔGel | ΔGvdw | Suma | Gcalcb | ΔGexp | ΔGel | ΔGvdw | Suma | Gcalcb | ΔGexp | ΔGel | ΔGvdw | Suma | Gcalcb | ΔGexp | |
1BZA | −5.9 | −2.0 | −7.9 | −8.6 | −7.1 | −6.3 | −2.0 | −8.3 | −8.0 | −6.8 | −6.4 | −1.9 | −8.3 | −7.6 | −6.3 |
2BEA | −1.4 | −2.1 | −3.5 | −4.2 | −5.2 | −2.4 | −2.2 | −4.6 | −4.3 | −5.0 | −0.9 | −2.2 | −3.1 | −2.4 | −4.7 |
3PEA | −1.7 | −1.9 | −3.5 | −4.2 | −4.1 | −1.3 | −2.0 | −3.3 | −3.0 | −4.1 | −1.5 | −1.9 | −3.3 | −2.6 | −3.1 |
4PPA | −0.1 | −2.3 | −2.4 | −3.1 | −3.3 | −1.2 | −2.0 | −3.2 | −2.9 | −3.7 | 0.0 | −2.1 | −2.1 | −1.4 | −2.1 |
5PBA | −0.5 | −2.3 | −2.8 | −3.5 | −3.2 | −0.2 | −2.0 | −2.2 | −1.9 | −3.7 | −1.1 | −2.2 | −3.3 | −2.6 | −2.0 |
Δ Gexp = (−RT ln Ka)/4180 (kcal/mole), and Ka is from Table 1b.
a Long-range contribution from interactions between the ligand and the protein outside the simulations sphere, estimated using a Coulombic potential with high dielectric constant.
b The error in the calculated binding free energies is between 0.5 and 1.0 kcal/mole based on the difference in the free energies calculated from the first and the second half of the production phase of the simulations.
Discussion
The characterization of the three-dimensional structure and the energetics involved is one of the key elements required to understand many biological functions, and the interplay between experimental and theoretical research plays a central role in the understanding of molecular recognition at the atomic level. In this study, we have determined association constants for binding of five different inhibitors to three different trypsins, and eight X-ray structures have been solved to high resolution. The energetics of these complexes have further been examined by carrying out free energy calculations using molecular dynamics simulations and the LIE method.
The role of the primary binding (S1) site of trypsin is well documented from mutation studies and from crystal structure analysis. Previous studies have shown that a number of factors are responsible for binding of ligands to the S1 site of trypsin. The electrostatic interaction between Asp 189 and positively charged ligands is the primary specificity determinant, but effects from hydrophobic interactions, solvation energies, and optimization of water-mediated hydrogen bonding networks are also important factors in mediating binding specificity. Crystal structures of protein–ligand complexes at atomic resolution, and thermodynamic studies, are an important source of information for further exploring such fundamental questions. Resolving such issues is of great importance in a number of different fields and plays a fundamental role in studies of molecular recognition in general. When it comes to structure-based ligand design, information at the atomic level along with thermodynamic data are the only way to calibrate and develop more accurate scoring functions and efficient docking algorithms.
Overall binding pattern
The present study demonstrates that a wide range of amine and amidiniumtype molecules inhibits trypsin, but the great variation in inhibition potential is not fully understood. For example, the P1-Arg mutant of BPTI binds in the order of ~1015 M−1 (Ka, Krowarsch et al. 1999), whereas 1BZA binds in the range of ~105 M−1 and the similar amine inhibitors have a Ka <~102 M−1. By using the trypsin 1BZA complex as a reference, the amine group of all the other inhibitors superimposes approximately with one of the amidinium nitrogens of 1BZA. In general, the crystal structures show that the amine group of the inhibitor is directed toward one particular side of the S1 pocket, bound to Gly 219 O (Position1), in the 2BEA complexes, whereas it is directed toward the opposite side, and bound to Ser 190 Oγ(Position2), in the other complexes (Fig. 4C ▶–F). The interaction distances to Asp 189 are, however, significantly longer for the inhibitors bound at Position2 (3.1–3.5 Å) compared with 1BZA and 2BEA (2.7–2.9 Å; c.f. Tables 4,5), which in part give rise to the marked drop in association energy (Table 1b). No significant difference in the interaction pattern among the three trypsins is observed on accommodating the various ligands; the same binding mode is observed for each ligand with all three trypsins.
Kurinov and Harrison (1994) have studied binding of 2BEA analogs to BT (BT-FBA and BT-AMC) using X-ray crystallography, and a binding arrangement with the amine nitrogen atoms in Position1 is observed for these analogs. However, their interpretation of complexes with longer amine inhibitors shows a totally different binding pattern compared with our results. Superimposing their models of BT complexed with 3PEA, 4PPA, and 5PBA onto our models (Fig. 4D ▶–F) reveals that the inhibitors are placed deeper into the pocket. Their NH1 atoms have replaced the OW1 molecule and the second carbon connected to NH1 occupies Position2, which is usually a cation-binding site. The results from Kurinov and Harrison thus show a highly unusual binding arrangement of an amine type of ligand to trypsin, and to our knowledge this has not been seen for any other trypsin inhibitor complexes, neither with proteinase inhibitors (Rühlmann et al. 1973; Helland et al. 1998, 1999a,b) nor with complexes with small molecules (Whitlow et al. 1999; Maignan et al. 2000; Toyota et al. 2001). Our crystallization conditions are identical to those of Kurinov and Harrison, but nevertheless resulted in different space groups, P212121 and P3121, respectively. It is not obvious that a change in space group alone could give rise to such a difference, but we have no other plausible explanation for the dissimilarities in inhibitor binding pattern.
Experimental and theoretical association energies
The association measurements show that 1BZA is the most potent trypsin inhibitor of the five ligands included here, and it binds 1.6–1.9 kcal/mole more favorably than the second-best inhibitor, depending on the trypsin. The association energies for the amines increase with increasing chain length, making them less potent as trypsin inhibitors. The trend is similar for all three trypsins, but the reduction is more pronounced for BT than for AST and CST. In order to address the variation in the binding capacity among these ligands, free energy calculations were carried out using the LIE approach. With this method, the binding free energy is estimated as a sum of polar and nonpolar contributions, making the method a good choice to study the difference in binding capacity. Furthermore, the method is also one of few that allows the absolute binding free energy to be estimated, not only the relative such as with free energy perturbation and thermodynamic integration techniques (for reviews, see Kollmann 1993; Brandsdal et al. 2003).
All of the ligands investigated are ionizable and carry a net charge at pH 8.3 where the association measurements were performed. Because these ligands, except for 1BZA, are highly flexible, the estimation of the absolute binding free energies was very challenging. In particular, it was difficult to obtain stable and converged ligand-surrounding energies for the bound state, as the ligand is involved in an extensive hydrogen bonding network with several water molecules as well as with charged residues in the protein. This delicate water-mediated hydrogen bonding network is actually the key to obtaining the correct binding free energies. The failure to reproduce the interaction pattern is clearly demonstrated by the 2BEA simulation when bound to BT, yielding a binding free energy 2.3 kcal/mole too positive. Nonetheless, the LIE method gave ΔGs that agree well with the experimental data, particularly for AST and CST, in which not only is the deviation from experiments low, but also the ranking of the ligands is very well reproduced. From the calculated free energies, the variation in the inhibition potency among the ligands seems to arise predominantly from subtle differences in the electrostatic interactions. As mentioned previously, the association constant becomes smaller (i.e., weaker binding or inhibition) when the length of the aliphatic chain of the amine increases. The LIE calculations clearly show that this is mainly caused by a change in the polar contribution to the free energy of binding (i.e., of electrostatic origin). In fact, the nonpolar contribution varies only with 0.2 to 0.4 kcal/mole, whereas the experimental free energy varies with 3.1 to 4.3 kcal/mole, depending on the ligand and the trypsin. The nonpolar contribution to the binding free energy is therefore virtually constant regardless of the ligand and trypsin, emphasizing the role of electrostatic interactions when explaining the variation in binding strength.
Cold-adaptation
Electrostatic interactions have been found to be an important feature of the cold-adaptation of the AST (Smalås et al. 1994; Leiros et al. 2000; Brandsdal et al. 2001b). Indeed, enhanced primary binding has been suggested to be an important factor when explaining the higher catalytic efficiency of AST relative to CST, BT, and porcine trypsin (Outzen et al. 1996). Increased catalytic activity is also observed for other cold-adapted trypsins (Osnes and Mohr 1985; Genicot et al. 1988; Ásgeirsson et al. 1989) and mainly attributed to lower Km values. Continuum electrostatics calculations showed that the active site of AST is more negatively charged in comparison to BT. This is primarily caused by the negative charges of Asp 150 and Glu 221B (shown in Fig. 5 ▶), indicating that enhanced electrostatic interactions could be a source of the observed 10-fold reduction in Km (Gorfe et al. 2000). Our previous LIE calculations (Brandsdal et al. 2001b), where 1BZA and P1 Arg and Lys variants of BPTI were bound to AST and BT, showed that the more favorable binding of these ligands to AST was caused by more optimized electrostatic interactions.
The main contribution to the total binding free energy is expected to arise from interactions within the S1-binding site for all of the ligands regardless of which trypsin they bind to, and that these forces are predominantly of short-range nature. The association measurements clearly show that the cold-adapted trypsin (AST) is more strongly inhibited by the positively charged ligands studied here, as compared with its warm-active counterpart (BT). This effect is most pronounced for binding of 1BZA, but it is also consistent for the less potent inhibitors. Despite this difference in binding capacity, the principal interactions in the active site cleft are virtually identical as judged from the high-resolution structures presented here, and also further supported by the free energy calculations, which show more or less the same interaction energies among the different enzymes for a given ligand (Tables 6, 7). However, the relative differences in binding are reproduced only when the contribution from distant ionic residues is added to the free energy (yielding ΔGcalc in Table 7). This contribution is −0.7, 0.3, and 0.7 kcal/mole for AST, CST, and BT, respectively, with the sign of this contribution reflecting the overall charge of the molecule. Other explanations for the increased catalytic capacity of AST compared with BT and CST have been found among the residues and structural features unique to the cold-adapted trypsins that are not found in CST (Leiros et al. 2000). These include the lack of Tyr 151 in AST, the unique orientation of residues 145–153 in the autolysis loop, the reduced interactions for the C-terminal residues, and the presence of the long residues Met 145 and Met 175 (Fig. 5 ▶), which together give the cold-adapted AST and CHST increased local flexibility that can explain the higher catalytic abilities.
Thus, the present study adds strong support to the hypothesis that electrostatic interactions play an important role in explaining the cold-adaptation of AST and its higher catalytic efficiency. It also confirms that the primary binding pattern is highly conserved but subtle differences arising from long-range effects cause the differences in binding affinities among the three trypsins studied here.
Materials and methods
Association constant measurements
AST and CST used for the binding constants measurements and structure determination were purified from the pancreatic tissue of Atlantic salmon (Outzen et al. 1996) and BT was purchased from Sigma (Type III).
The determination of association constants for the interactions between synthetic inhibitors and trypsin was performed using the Dixon method. Concentration of trypsins was determined by titration with 4-nitrophenyl 4-guanidinobenzoate (Chase and Shaw 1970). First, the steady-state parameters for the hydrolysis of the sensitive trypsin substrate Tos-Gly-Pro-Arg-pNA was determined in 100 mM Tris, 20 mM CaCl2 (pH 8.3) with a diode array spectrophotometer HP 8452A, as given in Table 1a. The calculated initial rates of the reaction were fitted by application of the nonlinear least squares analysis to the Briggs-Haldane equation. The final volume of the reaction mixture (1.8 mL) included 1 × 10−10 M to 4 × 10−10 M trypsin, and the substrate concentration varied from 0.1 × Km to about 3 × Km. The dissociation constants (Kd) were determined in similar experiments, keeping the substrate at a constant concentration. The inhibitor concentration varied from Kd to 0.3 × Kd. The dissociation constants were determined from the Dixon plot:
Finally, the association constants (Ka) were calculated (Ka = 1/Kd), and given in Table 1b.
Crystallization and data collection
Cocrystallization of AST and BT with the synthetic inhibitors (Fig. 1 ▶) was done by the hanging drop method. Crystals of AST were grown at 37°C with reservoir solutions of 0.7 M ammonium sulfate, 10 mM CaCl2, and 50 mM sodium citrate-phosphate (pH 6.0), and an initial protein concentration of 10 mg/mL (Berglund et al. 1995). One hundred millimolar of the inhibitors was added to the reservoirs, and, in order to dissolve the longest inhibitors (3PEA, 4PPA, 5PBA), it was necessary to add 10%–15% MPD. Crystals of BT were grown at room temperature with reservoir solutions containing 23%–25% polyethylene glycol 8000, 0.2 M ammonium sulphate, 0.1 M Tris buffer (pH 8) and 100 mM inhibitor, and an initial protein concentration of 15 mg/mL (Kurinov and Harrison 1994). Data were collected at ID14-EH4 and the Swiss Norwegian Beamline (SNBL), both at the European Synchrotron Radiation Facility (ESRF) in Grenoble, France, and at X31, DESY-lab, Hamburg, Germany. All data were integrated using DENZO (Otwinowski 1993), and scaling and merging were performed with SCALA from the CCP4 program suite (Collaborative Computational Project, No. 4 1994). Low R-merge values (4.8%–7.8%) and high completeness (90%–99%) were obtained for all complexes. See Tables 2 and 3 for details.
Phase determination and refinement
A new and third crystal form was found for the AST structures AST-2BEA and AST-4PPA. Initial phases for AST-2BEA were found by molecular replacement in AMoRe (Navaza 1994) with the AST crystal form II (PDB entry 1BIT) as a search model. The cross rotation and translation searches were done with data from 15–4.0 Å and an integration radius of 20 Å. The resulting Crowther angles and fractional translation vectors were α= 38.83, β= 65.97, γ= 263.42, Tx= −0.6188, Ty = 0.4560, and Tz = 1.0888. For the other AST structures, rigid body optimization from previously refined AST structures was sufficient (PDB entry 1BIT or 1HJ8; Berglund et al. 1995; Leiros et al. 2001). The phases for the BT structures were obtained using rigid body optimization from 1TNK (P212121) or 1C1Q (P3121) (Kurinov and Harrison 1994; Katz et al. 1998).
All structures were subjected to one cycle of simulated annealing (3000 K) in X-PLOR (Brünger 1992) using all data from 15 Å to the maximum resolution. Further refinement included alternate cycles of conjugated-gradient minimization and restrained temperature factor refinement with data from 8.0 Å to maximum resolution and rebuilding of the models using the graphics program O (Jones et al. 1991). Five percent to 10 percent of the data was kept out of refinement for cross validation, and the models were refitted on the basis of σa-weighted (Read 1986) 2Fo–Fc and Fo–Fc electron density maps. Solvent molecules were added to the models in which the difference density exceeded 3.5σ. For the structures refined with SHELXL (Sheldrick and Schneider 1997), rigid hydrogen atoms were added on all residues except the hydroxyl groups of Ser, Thr, and Tyr and the nitrogen atoms of the His side chains. Anisotropic B-factors were refined for the structures resolved to the highest resolution: AST-Free (free refers to no inhibitor), BT-2BEA, BT-3PEA, BT-5PBA, and BT-Free.
Structural comparison
The structures were compared by using the LSQKAB and CONTAC programs of the CCP4 program suite (Collaborative Computational Project, No. 4 1994) and O (Jones et al. 1991). Criteria for hydrogen bonds were a maximum distance of 3.5 Å between donor and acceptor, and a maximum angle of 120° O…H-N bonds and 90° O…O-C bonds.
Computational analysis
The interactions between the five synthetic inhibitors (Fig. 1 ▶) and AST, CST, and BT were subjected to computational analysis by the LIE method (Åqvist et al. 1994, 2002; Brandsdal et al. 2003).
The LIE approach estimates the polar and nonpolar contribution to the binding affinity separately using:
where < > is the molecular dynamics average of the nonbonded van der Waals (vdw) and electrostatic (el) interactions between the ligand and its surrounding environment (l-s). The Δ represents the change in these average energies between the bound and free states, and α and β are weight coefficients for the nonpolar and polar contribution, respectively. Here, we have used α = 0.18 and β = 0.5, because these values have previously been applied to trypsin with success (Wang et al. 1999; Brandsdal et al. 2001a).
Calculation of the absolute binding free energies of the ligands binding AST, CST, and BT was initiated from the six complex crystal structures presented here (Tables 3, 4), along with the high-resolution-resolved AST-1BZA and BT-ANL complexes (entries 1HJ8, 1HJ9; Leiros et al. 2001) and the CST-1BZA crystal structure (PDB entry 1A0J, Molecule B; Schrøder et al. 1998). The remaining complexes (AST with 5PBA, BT with 4PPA, CST in complex with the four amine inhibitors) were constructed from corresponding crystal structures with preservation of the hydrogen binding network and water molecules in the binding pocket (Fig. 4 ▶).
The free energy calculations were performed using the molecular dynamics program Q (Marelius et al. 1998) with the OPLS-AA force field (Jorgensen et al. 1996). Atomic charges for the ligands were set according to the force field scheme. The computational protocol used throughout the calculations is identical to the protocol described by Brandsdal et al. (2001a) except that an 18 Å simulations sphere was used here. The simulation center was defined to be the nitrogen atom of the amine ligands, and the carbon atom in the amidinium group of 1BZA. The nonbonded potentials involving the ligands were not subjected to any truncation schemes. Ionizable residues within 15 Å of the simulation center were considered charged along with the N-terminal residue, whereas distant ionizable residues were described using a neutral charge set. The contributions from these charges were taken into account using a screened Coulombic potential with ɛ = 80, because this has been found (Brandsdal et al. 2001b) to yield essentially the same contribution as with the sigmoidal dielectric function of Mehler and Eichele (1984). The production phase in which the ligand-surrounding interaction energies were sampled was 375 psec for all of the simulations.
Acknowledgments
We thank the organizers at SNBL and Seán M. McSweeney at ID14-EH4, ESRF, Grenoble, and the DESY-lab in Hamburg for providing us with beam time. The Norwegian Research Council is acknowledged for financial support.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 USC section 1734 solely to indicate this fact.
Abbreviations
AST, anionic salmon trypsin
CST, cationic salmon trypsin
BT, bovine trypsin
CHST, chum salmon trypsin
1BZA, benzamidine
2BEA, benzylamine
ANL, aniline
AMC, aminomethylcyclohexane
FBA, 4-fluorobenzyl
3PEA, phenylethylamine
4PPA, phenylpropylamine
5PBA, phenylbutylamine
BPTI, bovine pancreatic trypsin inhibitor
AST-BPTI, AST complexed with BPTI (1BZX)
BT-1BZA, BT complexed with benzamidine (3PTB)
BT-FBA, BT with 4-fluorobenzylamine (1TNH)
BT-AMC, BT with amino-methylcyclohexane (1TNG)
BT-3PEA, BT with phenylethylamine (1TNJ)
BT-4PPA, BT with phenylpropylamine (1TNK)
BT-5PBA, BT with phenylbutylamine (1TNI)
BT-K15G, BT complexed with BPTI and P1 Gly (3BTG)
BT-K15F, BT complexed with BPTI and P1 Phe (3BTP)
LIE, linear interaction energy
MPD, 2-methyl-2,4-pentanediol
GOL, glycerol
MD, molecular dynamics
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.03498604.
References
- Åqvist, J., Medina, C., and Samuelsson, J.E. 1994. A new method for predicting binding affinity in computer-aided drug design. Protein Eng. 7 385–391. [DOI] [PubMed] [Google Scholar]
- Åqvist, J., Luzhkov, V.B., and Brandsdal, B.O. 2002. Ligand binding affinities from MD simulations. Acc. Chem. Res. 35 358–365. [DOI] [PubMed] [Google Scholar]
- Ásgeirsson, B., Fox, J.W., and Bjarnason, J.B. 1989. Purification and characterization of trypsin from the poikilotherm Gadus morhua. Eur. J. Biochem. 180 85–94. [DOI] [PubMed] [Google Scholar]
- Berglund, G.I., Smalås, A.O., Hordvik, A., and Willassen, N.P. 1995. Structure of anionic salmon trypsin in a second crystal form. Acta Crystallogr. D 51 725–730. [DOI] [PubMed] [Google Scholar]
- Brandsdal, B.O., Åqvist, J., and Smalås, A.O. 2001a. Computational analysis of binding of P1 variants to trypsin. Protein Sci. 10 1584–1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brandsdal, B.O., Smalås, A.O., and Åqvist, J. 2001b. Electrostatic effects play a central role in cold adaptation of trypsin. FEBS Lett. 499 171–175. [DOI] [PubMed] [Google Scholar]
- Brandsdal, B.O., Österberg, F., Almlöf, M., Feierberg, I., Luzhkov, V.B., and Åqvist, J. 2003. Free energy calculations and ligand binding. Adv. Protein Chem. 66 123–158. [DOI] [PubMed] [Google Scholar]
- Brünger, A.T. 1992. X-PLOR, version 3.1, a system for X-ray crystallography and NMR. Yale University Press, New Haven,CT.
- Chase, T. and Shaw, E. 1970. Titration of trypsin, plasmin and thrombin with p-Nitrophenyl-p-guanidinobenzoate HCl: A new active site titrant for trypsin. Methods Enzymol. 19 20–27. [Google Scholar]
- Collaborative Computational Project, No. 4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50 760–763. [DOI] [PubMed] [Google Scholar]
- Esnouf, R.M. 1997. An extensively modified version of MolScript that included greatly enhanced coloring capabilities. J. Mol. Graph. 15 132–134. [DOI] [PubMed] [Google Scholar]
- Genicot, S., Feller, G., and Gerday, C. 1988. Trypsin from antarctic fish (Papanotothenia magellanica forster) as compared with trout (Salmo gairdneri) trypsin. Comp. Biochem. Physiol. B90 601–609. [Google Scholar]
- Gorfe, A.A., Brandsdal, B.O., Leiros, H.K.S., Helland, R., and Smalås, A.O. 2000. Electrostatics of mesophilic and psychrophilic trypsin isoenzymes: Qualitative evaluation of electrostatic differences at the substrate binding site. Proteins 40 207–217. [PubMed] [Google Scholar]
- Hedstrom, L. 1996. Trypsin: A case study in the structural determinants of enzyme specificity. Biol. Chem. 377 465–470. [PubMed] [Google Scholar]
- Hedstrom, L., Szilagy, L., and Rutter, W.J. 1992. Converting trypsin to chymotrypsin: The role of surface loops. Science 255 1249–1253. [DOI] [PubMed] [Google Scholar]
- Hedstrom, L., Perona, J.J., and Rutter, W.J. 1994a. Converting trypsin to chymotrypsin: Residue 172 is a substrate specificity determinant. Biochemistry 33 8757–8763. [DOI] [PubMed] [Google Scholar]
- Hedstrom, L., Farr-Jones, S., Kettner, C.A., and Rutter, W.J. 1994b. Converting trypsin to chymotrypsin: Ground-state binding does not determine substrate specificity. Biochemistry 33 8764–8769. [DOI] [PubMed] [Google Scholar]
- Helland, R., Leiros, I., Willassen, N.P., Berglund, G.I., and Smalås, A.O. 1998. The crystal structure of anionic salmon trypsin in complex with bovine pancreatic trypsin inhibitor. Eur. J. Biochem. 256 317–324. [DOI] [PubMed] [Google Scholar]
- Helland, R., Berglund, G.I., Otlewski, J., Apostoluk, W., Andersen, O.A., Willassen, N.P., and Smalås, A.O. 1999a. High resolution crystal structures of three new trypsin-squash inhibitor complexes: A detailed comparison with other trypsins and their complexes. Acta Crystallogr. D 55 138–148. [DOI] [PubMed] [Google Scholar]
- Helland, R., Otlewski, J., Sundheim, O., Dadlez, M., and Smalås, A.O. 1999b. Crystal structures of the complexes between bovine β-trypsin and ten P1 variants of BPTI. J. Mol. Biol. 287 923–942. [DOI] [PubMed] [Google Scholar]
- Hung, S.H. and Hedstrom, L. 1998. Converting trypsin to elastase: Substitution of the S1 site and adjacent loops reconstitutes esterase specificity but not amidase activity. Protein Eng. 11 669–673. [DOI] [PubMed] [Google Scholar]
- Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 110–119. [DOI] [PubMed] [Google Scholar]
- Jorgensen, W.L., Maxwell, D.S., and Tirado-Rives, J. 1996. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118 11225–11236. [Google Scholar]
- Katz, B.A., Clark, J.M., Finer-Moore, J.S., Jenkins, T.E., Johnson, C.R., Ross, M.J., Luong, C., Moore, W.R., and Stroud, R.M. 1998. Design of potent selective zinc-mediated serine protease inhibitors. Nature 391 608–612. [DOI] [PubMed] [Google Scholar]
- Kollmann, P. 1993. Free energy calculations: Applications to chemical and biochemical phenomena. Chem. Rev. 93 2395–2417. [Google Scholar]
- Kristjansson, M.M., Ásgeirsson, B., and Bjarnason, J.B. 1997. Serine proteinases from cold-adapted organisms. Adv. Exp. Med. Biol. 415 27–46. [DOI] [PubMed] [Google Scholar]
- Krowarsch, D., Dadlez, M., Buczek, O., Krokoszynska, I., Smalås, A.O., and Otlewski, J. 1999. Interscaffolding additivity: Binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteinases. J. Mol. Biol. 289 175–186. [DOI] [PubMed] [Google Scholar]
- Kurinov, I.V. and Harrison, R.W. 1994. Prediction of new serine proteinase inhibitors. Nat. Struct. Biol. 1 735–743. [DOI] [PubMed] [Google Scholar]
- Leiros, H.-K.S., Willassen, N.P., and Smalås, A.O. 2000. Structural comparison of psychrophilic and mesophilic trypsins. Elucidating the molecular basis of cold-adaptation. Eur. J. Biochem. 267 1039–1049. [DOI] [PubMed] [Google Scholar]
- Leiros, H.-K.S., McSweeney, S.M., and Smalås, A.O. 2001. Atomic resolution structures of trypsin provide insight into structural radiation damage. Acta Crystallogr. D 57 488–497. [DOI] [PubMed] [Google Scholar]
- Luzatti, V. 1952. Traitement Statistique des Erreurs dans la Determination des Structures Cristaaines. Acta Crystallogr. 5 802–810. [Google Scholar]
- Maignan, S., Guilloteau, J.P., Pouzieux, S., Choi-Sledeski, Y.M., Becker, M.R., Klein, S.I., Ewing, W.R., Pauls, H.W., Spada, A.P., and Mikol, V. 2000. Crystal structures of human factor Xa complexed with potent inhibitors. J. Med. Chem. 43 3226–3232. [DOI] [PubMed] [Google Scholar]
- Marelius, J., Kolmodin, K., Feierberg, I., and Åqvist, J. 1998. Q: A molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems. J. Mol. Graph. Model. 16 213–225, 261. [DOI] [PubMed] [Google Scholar]
- Marquart, M., Walter, J., Deisenhofer, J., Bode, W., and Huber, R. 1983. The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors. Acta Crystallogr. B 39 480–490. [Google Scholar]
- Mehler, E.I. and Eichele, G. 1984. Electrostatic effects in water-accessible regions of proteins. Biochemistry 23 3887–3891. [Google Scholar]
- Osnes, K.K. and Mohr, V. 1985. On the purification and characterization of three anionic, serine-type peptide hydrolases from Antarctic krill Euphausia superba. Comp. Biochem. Physiol. B 82 607–619. [Google Scholar]
- Otwinowski, Z. 1993. DENZO: An oscillation data processing program for macromolecular crystallography. Yale University, New Haven, CT.
- Outzen, H., Berglund, G.I., Smalås, A.O., and Willassen, N.P. 1996. Temperature and pH sensitivity of trypsins from Atlantic salmon (Salmo salar) in comparison with bovine and porcine trypsin. Comp. Biochem. Physiol. B 115 33–45. [DOI] [PubMed] [Google Scholar]
- Perona, J.J. and Craik, C.S. 1997. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J. Biol. Chem. 272 29987–29990. [DOI] [PubMed] [Google Scholar]
- Read, R.J. 1986. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. A 42 140–149. [Google Scholar]
- Rühlmann, A., Kukla, D., Schwager, P., Bartels, K., and Huber, R. 1973. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. J. Mol. Biol. 77 417–436. [DOI] [PubMed] [Google Scholar]
- Schechter, I. and Berger, A. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 157–162. [DOI] [PubMed] [Google Scholar]
- Schrøder, H.-K., Willassen, N.P., and Smalås, A.O. 1998. Structure of a non-psychrophilic trypsin from a cold-adapted fish species. Acta Crystallogr. D 554 780–798. [DOI] [PubMed] [Google Scholar]
- Sekizaki, H., Itoh, K., Murakami, M., Toyota, E., and Tanizawa, K. 2000. Anionic trypsin from chum salmon: Activity with p-amidinophenyl ester and comparison with bovine and Streptomyces griseus trypsins. Comp. Biochem. Physiol. 127B 337–346. [DOI] [PubMed] [Google Scholar]
- Sheldrick, G.M. and Schneider, T.R. 1997. SHELXL: High-resolution refinement. Methods Enzymol. 277 319–343. [PubMed] [Google Scholar]
- Smalås, A.O., Heimstad, E.S., Hordvik, A., Willassen, N.P., and Male, R. 1994. Cold adaption of enzymes: Structural comparison between salmon and bovine trypsins. Proteins 20 149–166. [DOI] [PubMed] [Google Scholar]
- Smalås, A.O., Leiros, H.-K.S., Os, V., and Willassen, N.P. 2000. Cold adapted enzymes. Biotechnol. Annu. Rev. 6 1–57. [DOI] [PubMed] [Google Scholar]
- Toyota, E., Ng, K.K., Sekizaki, H., Itoh, K., Tanizawa, K., and James, M.N. 2001. X-ray crystallographic analyses of complexes between bovine β-trypsin and Schiff base copper(II) or iron(III) chelates. J. Mol. Biol. 305 471–419. [DOI] [PubMed] [Google Scholar]
- Toyota, E., Ng, K.K., Kuninaga, S., Sekizaki, H., Itoh, K., Tanizawa, K., and James, M.N. 2002. Crystal structure and nucleotide sequence of an anionic trypsin from chum salmon (Oncorhynchus keta) in comparison with Atlantic salmon (Salmo salar) and bovine trypsin. J. Mol. Biol. 324 391–397. [DOI] [PubMed] [Google Scholar]
- Wang, W., Wang, J., and Kollman, P.A. 1999. What determines the van der Waals coefficient β in the LIE (linear interaction energy) method to estimate binding free energies using molecular dynamics simulations? Proteins 34 395–402. [PubMed] [Google Scholar]
- Whitlow, M., Arnaiz, D.O., Buckman, B.O., Davey, D.D., Griedel, B., Guilford, W.J., Koovakkat, S.K., Liang, A., Mohan, R., Phillips, G.B., et al. 1999. Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin. Acta Crystallogr. D 55 1395–1404. [DOI] [PubMed] [Google Scholar]